161 related articles for article (PubMed ID: 33655597)
1. CDH1 variants leading to gastric cancer risk management decision-making experiences in emerging adults: 'I am not ready yet'.
Liu Y; Calzone K; Fasaye GA; Quillin J
J Genet Couns; 2021 Aug; 30(4):1091-1104. PubMed ID: 33655597
[TBL] [Abstract][Full Text] [Related]
2. Young people's experiences of a CDH1 pathogenic variant: Decision-making about gastric cancer risk management.
Hoskins C; Tutty E; Purvis R; Shanahan M; Boussioutas A; Forrest L
J Genet Couns; 2022 Feb; 31(1):242-251. PubMed ID: 34265132
[TBL] [Abstract][Full Text] [Related]
3. Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy.
McGarragle KM; Hart TL; Swallow C; Brar S; Govindarajan A; Cohen Z; Aronson M
Fam Cancer; 2021 Apr; 20(2):157-169. PubMed ID: 32754788
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
5. Decision-making and regret in patients with germline
Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
7. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers.
Bryant MK; Sillcox R; Grady WM; Oelschlager BK
Surg Endosc; 2023 Dec; 37(12):9373-9380. PubMed ID: 37644154
[TBL] [Abstract][Full Text] [Related]
8. Optimal Timing of Total Gastrectomy to Prevent Diffuse Gastric Cancer in Individuals With Pathogenic Variants in CDH1.
Laszkowska M; Silver ER; Schrope B; Kastrinos F; Wang TC; Hur C
Clin Gastroenterol Hepatol; 2020 Apr; 18(4):822-829.e4. PubMed ID: 31220641
[TBL] [Abstract][Full Text] [Related]
9. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
11. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
Kumar S; Long JM; Ginsberg GG; Katona BW
World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
13. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
[TBL] [Abstract][Full Text] [Related]
14. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
[TBL] [Abstract][Full Text] [Related]
15. CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN; Davis JL
Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
[TBL] [Abstract][Full Text] [Related]
16. Becoming and being a parent with an inherited predisposition to diffuse gastric cancer: A qualitative study of young adults with a
Tutty E; Forbes Shepherd R; Hoskins C; Purvis R; Shanahan M; Boussioutas A; Forrest LE
J Psychosoc Oncol; 2023; 41(3):286-302. PubMed ID: 35959852
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy after prophylactic total gastrectomy.
Kaurah P; Fitzgerald R; Dwerryhouse S; Huntsman DG
Fam Cancer; 2010 Sep; 9(3):331-4. PubMed ID: 20063069
[TBL] [Abstract][Full Text] [Related]
18. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review.
Gamble LA; Heller T; Davis JL
JAMA Surg; 2021 Apr; 156(4):387-392. PubMed ID: 33404644
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
[TBL] [Abstract][Full Text] [Related]
20. Emerging Adults Carrying a CDH1 Pathogenic or Likely Pathogenic Variant Face Diet and Lifestyle Challenges after Total Gastrectomy.
Liu Y; Lopez R
J Acad Nutr Diet; 2022 May; 122(5):913-917. PubMed ID: 34968751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]